Fact CheckerSign in

NCT05589584CompletedPhase 3

N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease

Effect of N-acetyl Cysteine on Markers of Oxidative Stress and Insulin Resistance in Patients with Non-alcoholic Fatty Liver Disease

Source: ClinicalTrials.gov · Last updated 17 Oct 2024

Brief summary (registry, in English)

Effect of N-acetyl cysteine on markers of oxidative stress and insulin resistance in patients with Non-alcoholic fatty liver disease

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
60 (actual)
First submitted
18 Oct 2022
Start date
1 Nov 2022
Primary completion date
20 May 2024
Lead sponsor
Ain Shams University
NCT number
NCT05589584

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 60
  • From 1 Nov 2022 to the primary completion date, 20 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • current Consumption of any antioxidant supplements and hepatotoxic drug.

Other illness

  • History of alcohol consumption, drug addiction or the use of medications known to precipitate steatohepatitis.
  • Patients with schistosomiasis, active hepatitis B or C, autoimmune and diabetes mellitus.
  • Active Cancer patients.
  • Anyone having hypersensitivity to N-acetylcysteine.

Other

  • Pregnancy or lactation or expecting to get pregnant during the study.
  • Medical, psychological, or pharmacological factors interfering with the collection or interpretation of study data.
  • Anyone already taking N-acetylcysteine.

Who the study is looking for

  • Males or females aged 18-60 years diagnosed with NAFLD

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NHTMRI
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.